ASX ANNOUNCEMENT 28 October 2026 September 2026 Quarterly Activities Report PainChek advances commercial changes as US and UK customer wins build • Revised commercial strategy focuses execution on priority residential aged care markets • Changes across leadership, operations and the Board...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Earlier from PainChek
- PainChek wins 1,800-licence UK contract with Hallmark
- PainChek expands Sabra contracts to 23 US communities
- Appendix 4E and Financial Report
- PainChek receives $1.123 million R&D tax incentive refund
- US MedTech leader Karen Holzberger appointed CEO
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek